WAM
LXRX icon

World Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

World Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,570
Closed -$15K – 1440
2014
Q3 		$15K Hold
1,570
– – ﹤0.01% 1485
2014
Q2 		$18K Sell
1,570
-317
-17% -$3.4K ﹤0.01% 1529
2014
Q1 		$23K Buy
1,887
+96
+5% +$1.23K ﹤0.01% 1517
2013
Q4 		$23K Sell
1,791
-783
-30% -$12.5K ﹤0.01% 1554
2013
Q3 		$43K Sell
2,574
-3,638
-59% -$61K ﹤0.01% 1688
2013
Q2 		$94K Buy
+6,212
New +$94.4K ﹤0.01% 1694

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

World Asset Management's LXRX Position: Q4 2014 in Review

World Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2014, closing a stake of 1,570 shares — an estimated $15K sold.

World Asset Management first reported a position in LXRX in Q2 2013 and held it in 6 quarters. The position peaked at $94K in Q2 2013. 123 funds tracked by Wall St. Rank hold LXRX as of Q4 2014.

  • World Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • World Asset Management sold 1,570 Lexicon Pharmaceuticals shares in Q4 2014, an estimated $15K.
  • World Asset Management first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • World Asset Management's Lexicon Pharmaceuticals position peaked at $94K in Q2 2013.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2014.

Based on World Asset Management's 13F filing for Q4 2014, filed 5 Feb 2015.